Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | ||
Ligand | BDBM285551 | ||
Substrate/Competitor | n/a | ||
IC50 | >2150±n/a nM | ||
Citation | Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM Imidazopyridazine compounds US Patent US9598421 Publication Date 3/21/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | |||
Name: | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | ||
Synonyms: | 3',5'-cyclic phosphodiesterase | DPDE3 | PDE43 | PDE4D | PDE4D_HUMAN | Phosphodiesterase 4D | ||
Type: | Protein | ||
Mol. Mass.: | 91092.69 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q08499 | ||
Residue: | 809 | ||
Sequence: |
| ||
BDBM285551 | |||
n/a | |||
Name | BDBM285551 | ||
Synonyms: | 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile | US10077269, Example 24 | US10669279, Example 24 | US9598421, Example 24 | ||
Type | Small organic molecule | ||
Emp. Form. | C17H11F2N5O | ||
Mol. Mass. | 339.2989 | ||
SMILES | Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)| | ||
Structure |